Jim Cramer's Mad Dash: Buy CVS Health Over Rite Aid, ConAgra Over General Mills

NEW YORK (TheStreet) -- "This guidance is horrendous," TheStreet's Jim Cramer said of Rite Aid's (RAD) recent earnings report. Shares of the drugstore company are down over 15% as a result. 

On CNBC's "Cramer's Mad Dash" segment, Cramer, the co-manager of the Action Alerts PLUS portfolio, said Rite Aid's management should have seen the drop in earnings ahead of time.

"This is unacceptable to say that this was unpredictable," he added, referring to management expecting the drop in exclusivity to certain generic drugs. 

Read More: 10 Stocks Carl Icahn Loves in 2014

Instead, Cramer said, investors should just stay long CVS Health (CVS) . 

Turning to ConAgra Foods (CAG) , the company beat earnings expectations after seeing a positive turnaround in some of its packaged foods brands. 

When investors consider the possible "stability" in its business coupled with its dividend and strong balance sheet, ConAgra Foods is a better buy than General Mills (GIS) , Cramer stated. 

Read More: Yahoo!'s Alibaba Cash Could Trigger a Buying Binge in Tech

However, "I don't want to own any packaged good stocks other than WhiteWave Foods (WWAV) and Hain Celestial Group (HAIN) , Cramer said.


- - Written by Bret Kenwell in Petoskey, Mich.

Follow @BretKenwell

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.

If you liked this article you might like

Walgreens Is Primed to Rally, With or Without Rite Aid

S&P 500 and Dow Score Records With Wall Street Upbeat Ahead of Fed

S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed

Walgreens to Tweak Number of Rite Aid Stores It Buys to Win Regulatory Approval

Will the FTC Let Walgreens Go on a $5.2 Billion Rite Aid Shopping Spree?